Evidence map›Paper›PMID 41030881›Full record

ArticleQatar medical journal2025

Use of mebendazole (anthelmintic) for recurrent uncomplicated urinary tract infections in a healthy female: A case report.

Ibtisam Musameh, Zeinab Abdel Mohsen, Asmaa Mohamed

Abstract read
In one paragraph

Article in Qatar medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ibtisam MusamehPharmacy Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
Zeinab Abdel MohsenHamad Medical Corporation, Doha, Qatar.
Asmaa MohamedHamad General Hospital, Hamad Medical Corporation, Doha, Qatar *Email: imusameh@hamad.qa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Recurrent uncomplicated urinary tract infections (UTIs) in healthy females pose a significant challenge to both patients and healthcare professionals, due to the need for repeated antibiotic treatments and the recurrence of symptoms and suffering. This case report suggests a potentially simple approach to treating recurrent uncomplicated UTI in a healthy, sexually active female, which, if validated, may eliminate the need for frequent antibiotic courses and long-term prophylactic use, potentially leading to a complete cure. Case presentation: A 35-year-old healthy, sexually active Middle Eastern female was diagnosed with a recurrent uncomplicated UTI. The patient received multiple courses of culture-guided antibiotics, including ertapenem, for over a period of two years. The patient inadvertently recovered from the disease after she and her family received mebendazole treatment, following the diagnosis of a pinworm infestation in her five-year-old child. All patients' symptoms resolved, with no recurrence of urinary tract infections or need for antibiotics during the two-year follow-up period after mebendazole administration. The patient remained sexually active throughout the follow-up period without any lifestyle modifications. Discussion: Recurrent urinary tract infections (rUTIs) in healthy females remain a significant medical challenge as there is no established hypothesis to explain why some women are more susceptible to rUTIs than others. While pinworm ( Conclusion: This case raises the question of whether empirical treatment with mebendazole should be considered for recurrent uncomplicated UTIs in sexually active, healthy females - alongside standard antibiotic therapy. Identifying pinworm infection in healthy adult females with rUTIs could provide valuable insights, particularly if an association between the two is confirmed.

Indexed as

anthelminticcase reportmebendazolepinwormRecurrent urinary tract infection

Identifiers

PMID41030881
PMCPMC12477819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.